U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381231) titled 'Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors' on Dec. 01, 2025.
Brief Summary: The goal of this clinical trial is to find out whether Adaptive Pulse Radiotherapy (Pulse RT) combined with immune checkpoint inhibitors (ICIs) helps treat advanced solid tumors.
It will also check how safe this combined treatment is and how it affects the immune system and quality of life.
The main questions the study will try to answer are:
Does adding Pulse RT to ICIs improve tumor response and survival? What side effects occur when participants receive Pulse RT with ICIs? How does the treatment change immune-related blood and tissu...